Quotes

Back To Menu

Bafna Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Small Cap

Invest

15 Nov 2018 | 12:00 AM

14.69
0.39 (2.73%)

  • Underperforms Index

    -37.62%

    Return (1Y)

    Underperformed S&P BSE Sensex by 44.72%

  • More Volatile

    3.01%

    Standard Deviation (1Y)

    Higher than S&P BSE Sensex by 2.26%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Sensex

  • AxisDirect View

    No View

52 Week High-Low

30

30.35

11

10.91

News & Announcements

  • Bafna Pharmaceuticals reports standalone net loss of Rs 1.28 crore in the September 2018 quarter

    3 days ago

  • Bafna Pharmaceuticals announces board meeting date

    6 days ago

  • Bafna Pharmaceuticals AGM scheduled

    59 days ago

  • Board of Bafna Pharmaceuticals accepts resignation of director

    73 days ago

Price vs Volume

Stock Trivia

  • Promoter shareholding in Bafna Pharmaceuticals Ltd has decreased by -21.14% since past 1 Year

  • Bafna Pharmaceuticals Ltd has opened at 13.5 i.e -4.59% below then yesterday's closing price of 14.15

  • Bafna Pharmaceuticals Ltd has the Lowesr P/E ratio according to FY 201803 data among stocks in Pharmaceuticals Sector

  • Bafna Pharmaceuticals Ltd has the Lowesr P/B ratio according to FY 201803 data among stocks in Pharmaceuticals Sector

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...